Remove Biosimilars Remove Generic Medicine Remove Packaging
article thumbnail

Indian pharma industry in 21st century – What has changed for domestic supply?

Express Pharma

We are basking in the glory of NDAs, ANDAs, new molecules, biosimilars, and technological advances coupled with quality optimisation and training at the global level at par with Europe, the US, and Japan, doubling and trebling international trade in the next five years.

article thumbnail

Standards support medicines supply chain resilience and the future of quality

Quality Matters

Quality across the product lifecycle The role of standards goes far beyond the drug manufacturing process – from the sourcing of raw materials to packaging, labeling, distribution, and point-of-care administration – to help ensure quality across the pharmaceutical product lifecycle.

article thumbnail

Regulatory convergence is extremely important

Express Pharma

IGBA is the International Generic and Biosimilar Medicines Association. The association is formally set up in Switzerland, and it’s the trade association gathering the associations of generic and biosimilar medicines across the world. What is IGBA’s mandate? The products are getting more complex.